Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions

Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions

Chemotherapy induced peripheral neuropathy (CIPN) is an often severe and debilitating complication of multiple chemotherapeutic agents that can affect patients of all ages, across cancer diagnoses. CIPN can persist post-therapy, and significantly impact the health and quality of life of cancer survi...

Full description

Bibliographic Details
Main Authors:	Rozalyn L. Rodwin, Namrah Z. Siddiq, Barbara E. Ehrlich, Maryam B. Lustberg
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Pain Research
Subjects:	chemotherapy-induced peripheral neuropathy (CIPN) paclitaxel vincristine bortezomib biomarkers oxaliplatin
Online Access:	https://www.frontiersin.org/articles/10.3389/fpain.2022.864910/full

Similar Items

Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine
by: David Balayssac, et al.
Published: (2023-12-01)

Development of an In Vitro Assessment Method for Chemotherapy-Induced Peripheral Neuropathy (CIPN) by Integrating a Microphysiological System (MPS) with Morphological Deep Learning of Soma and Axonal Images
by: Kazuki Matsuda, et al.
Published: (2023-10-01)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01)

Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice
by: Aryah Basu, et al.
Published: (2024-01-01)

Skin Extracellular Matrix Breakdown Following Paclitaxel Therapy in Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Nathan P. Staff, et al.
Published: (2023-08-01)

Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2
by: Hee Seong Cho, et al.
Published: (2023-01-01)

Longitudinal RNA Sequencing of Skin and DRG Neurons in Mice with Paclitaxel-Induced Peripheral Neuropathy
by: Anthony M. Cirrincione, et al.
Published: (2022-05-01)

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
by: Hana Starobova, et al.
Published: (2017-05-01)

Targeting drug transporters to prevent chemotherapy-induced peripheral neuropathy
by: Kevin M. Huang, et al.
Published: (2021-01-01)

Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes
by: Sebastian W. Nielsen, et al.
Published: (2022-03-01)

New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy
by: Janet Schloss, et al.
Published: (2016-01-01)

Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
by: Shota Yamamoto, et al.
Published: (2021-01-01)

Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01)

Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis
by: Megan Crichton, et al.
Published: (2022-06-01)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
by: Yang Li, et al.
Published: (2021-02-01)

Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms
by: L. Brett Whalen, et al.
Published: (2022-02-01)

Exercise for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials
by: Yingjie Huang, et al.
Published: (2024-01-01)

Corrigendum: Exercise for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials
by: Yingjie Huang, et al.
Published: (2024-03-01)

Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center
by: Florent Bienfait, et al.
Published: (2023-01-01)

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)
by: Hiroaki Tanioka, et al.
Published: (2019-10-01)

The Role of Interleukin-20 in Paclitaxel-Associated Peripheral Neuropathy in Non-Metastatic Breast Cancer Patients Receiving Chemotherapy
by: Kubilay Karaboyun, et al.
Published: (2023-11-01)

Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κB
by: Jing Meng, et al.
Published: (2019-04-01)

Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials
by: Chenkun Wang, et al.
Published: (2022-12-01)

Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants
by: Maho Tsubota, et al.
Published: (2019-10-01)

A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy
by: Yusuke Fukuda, et al.
Published: (2017-08-01)

Gabapentin and Duloxetine Prevent Oxaliplatin- and Paclitaxel-Induced Peripheral Neuropathy by Inhibiting Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Phosphorylation in Spinal Cords of Mice
by: Natsuki Kato, et al.
Published: (2020-12-01)

Managing treatment-related peripheral neuropathy in patients with multiple myeloma
by: Grammatico S, et al.
Published: (2016-06-01)

Electrophysiologic Patterns of Symptomatic Vincristine-Induced Peripheral Neuropathy in Children with Acute Lymphocytic Leukemia
by: Jae-Gyeong Jeong, et al.
Published: (2023-01-01)

Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients
by: Nicolette Tay, et al.
Published: (2022-10-01)

Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial
by: Bernardino Clavo, et al.
Published: (2021-03-01)

Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy
by: Fumiko Sekiguchi, et al.
Published: (2020-12-01)

Mechanisms of Chemotherapy-Induced Neurotoxicity
by: Halina Was, et al.
Published: (2022-03-01)

Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
by: Zia Khan, et al.
Published: (2023-06-01)

Kratom alkaloid mitragynine: Inhibition of chemotherapy-induced peripheral neuropathy in mice is dependent on sex and active adrenergic and opioid receptors
by: Daniel J. Farkas, et al.
Published: (2022-12-01)

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
by: Nicolas Kerckhove, et al.
Published: (2021-11-01)

Efficacy of electroacupuncture in the treatment of peripheral neuropathy caused by Utidelone: Study protocol for a randomized controlled trial
by: Chao Lu, et al.
Published: (2023-02-01)

Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice
by: Urszula O. Warncke, et al.
Published: (2021-07-01)

Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
by: Karolina Łuczkowska, et al.
Published: (2022-02-01)

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2021-07-01)

Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy (CIPN) with Non-Pharmacological Interventions: Clinical Recommendations from a Systematic Scoping Review and an Expert Consensus Process
by: Nadja Klafke, et al.
Published: (2023-01-01)